Andlauer Healthcare Group (AND) Stock Forecast, Price & News

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Andlauer Healthcare Group in the last year. There are currently 3 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" AND shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AND, but not buy additional shares or sell existing shares.
View AND analyst ratings or view top-rated stocks.

5 equities research analysts have issued 1 year price targets for Andlauer Healthcare Group's stock. Their AND share price forecasts range from C$50.00 to C$65.00. On average, they predict the company's share price to reach C$56.68 in the next twelve months. This suggests a possible upside of 22.3% from the stock's current price.
View analysts price targets for AND or view top-rated stocks among Wall Street analysts.

Andlauer Healthcare Group's stock was trading at C$47.35 at the start of the year. Since then, AND shares have decreased by 2.1% and is now trading at C$46.36.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 8th 2023.
View our AND earnings forecast.

Andlauer Healthcare Group Inc. (TSE:AND) issued its earnings results on Wednesday, May, 3rd. The company reported $0.39 earnings per share for the quarter, missing the consensus estimate of $0.42 by $0.03. The company had revenue of $164.77 million for the quarter, compared to analysts' expectations of $156.35 million. Andlauer Healthcare Group had a trailing twelve-month return on equity of 18.50% and a net margin of 11.48%.

Andlauer Healthcare Group announced a quarterly dividend on Wednesday, March 15th. Stockholders of record on Friday, March 31st will be given a dividend of 0.08 per share on Monday, April 17th. This represents a $0.32 annualized dividend and a dividend yield of 0.69%. The ex-dividend date is Thursday, March 30th. This is a positive change from the stock's previous quarterly dividend of C$0.07.
Read our dividend analysis for AND.

Andlauer Healthcare Group (TSE:AND) pays an annual dividend of C$0.32 per share and currently has a dividend yield of 0.71%. The dividend payout ratio is 17.88%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for AND.

Based on aggregate information from My MarketBeat watchlists, some companies that other Andlauer Healthcare Group investors own include Lightspeed Commerce (LSPD), Aurora Cannabis (ACB), AltaGas (ALA), Automotive Properties Real Est Invt TR (APR.UN), Alteryx (AYX), Boeing (BA), Boralex (BLX), Bristol-Myers Squibb (BMY), Berkshire Hathaway (BRK.B) and Capricor Therapeutics (CAPR).

Andlauer Healthcare Group trades on the Toronto Stock Exchange (TSX) under the ticker symbol "AND."

Shares of AND stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

One share of AND stock can currently be purchased for approximately C$46.36.

Andlauer Healthcare Group (TSE:AND) has a market capitalization of C$930.45 million and generates C$664.85 million in revenue each year. The company earns C$76.33 million in net income (profit) each year or C$1.79 on an earnings per share basis.

The company employs 1,800 workers across the globe.

The official website for the company is www.andlauerhealthcare.com. The company can be reached via phone at 416 744 4900.